medigraphic.com
ISSN 1817-5996 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cub de Reu 2013; 15 (2)

Rheumatoid arthritis and pregnancy

López MAM, Reyes PY, Hernández CMI, Prada HD, Molinero RC

Language: Spanish
References: 31
Page:
PDF size: 147.67 Kb.


ABSTRACT

Rheumatoid arthritis during pregnancy is not a rare condition, considering higher prevalence of this disease in women during fertile period. The coexistence of both clinical conditions (rheumatoid arthritis and pregnancy) is always an important challenge for physicians in charge to these patients. It is accepted both that pregnancy has a protective influence for rheumatoid arthritis development, and symptoms frequently ameliorate during the pregnancy period and only be worst after delivery. It seems that Rheumatoid arthritis does not affect fertility ratio between female patients, neither increases abortion frequency, number of fetal death, nor pre-term birth in comparison with normal population. Nevertheless, it is recommended that treatment must be personalized, because most of anti-rheumatic drugs have adverse effects, some of them related to pregnancy well established in some drugs and with not enough information and the present time, for some others. Interdisciplinary medical care of pregnancy women with rheumatoid arthritis, including rheumatology doctor in the treatment team are important steps in order to reduce mothers, fetus and perinatal complications. In this paper we review rheumatoid arthritis related with pregnancy.


REFERENCES

  1. Scott D, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376: 1094-1108.

  2. Reino J. Artritis Reumatoide. En Manual SER de las Enfermedades Reumáticas, 5ta ed. Madrid .Medica Panamericana; 2008:190-199.

  3. Iebba F, Di Sora F, Tarasi A, Leti W, Montella F .Rheumatoid arthritis: a typical multifactorial genetic disease: review of the literature Recenti Prog Med. 2011;102(4):175-82.

  4. Gómez A. Nuevos criterios de clasificación de artritis reumatoide .Reumatol Clin. 2011; 6(3):33-37.

  5. Jain A, Gordon C. Managing pregnancy in inflammatory rheumatological diseases. Arthritis Research & Therapy. [revista en Internet]. 2011[citado 20 de marzo de 2013].13(206). Disponible en: http://arthritisresearch.com/content/13/1/206

  6. Suarez-Almazor ME, Osiri M, Emery P. Ottawa Methods group. Capítulo 9: Rheumatoid Arthritis .En: Evidence Based Rheumatology. Ottawa, BMJ Books. 2003: 243-314.

  7. Smolen JS, Aletaha D, Bijlsma JWJ. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010. 1239-19.

  8. Tornero Molina J, Sanmartí Sala R, Rodríguez Valverde V.. Actualización del documento de consenso de la sociedad española de reumatología sobre el uso de terapias biológicas en la artritis Reumatoide. Reumatol Clin. 2010; 6:23-36

  9. Martín Mola E; Hernández B; Garcia-Arias M; Álvaro-Gracia JM; Balsa A; Gómez Reino J et al. Consenso de uso de rituximab en artritis reumatoide. Un documento con recomendaciones basadas en la evidencia. Reumatol Clin. 2011; 7(1).

  10. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann. Rheum. Ois. 2007; 66: 143-50.

  11. Genovese MC. Abatecept for Rheumatoid Arthritis refractory to TNF alfa inhibition. NEJM. 2005; 353(11):1114-23.

  12. Smolen J, Beaulieu A, Rubbert-Roth A, Ramos-Remus C. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. The Lancet. 2008 March 22; Vol. 371: 76-91.

  13. Geiler J, Buch M, McDermott MF Anti-TNF treatment in rheumatoid arthritis. Curr Pharm Des. 2011; 17(29):3141-54.

  14. Hazes J, Coulie P, Geenen V, Veimeire S, Carbonnel F, Louis E et al.. Rheumatoid arthritis and pregnancy: Evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford). 2011; 50(11): 1955-68.

  15. Amin S, Peterson EJ , Reed AM , Mueller DL Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity. Curr Rheumatol Rep. 2011;13(5):449-55.

  16. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am. 1997; 23: 195-212.

  17. Alvarez-Nemegyei J, Cervantes-Diaz MT, Avila-Zapata F, Marin Ordonez J . Pregnancy outcomes before and after the onset of rheumatoid arthritis. Rev Med Inst Mex Seguro Soc. 2011 Nov-Dec;49(6):599-604.

  18. Sukenik Halevy, R, Sukenik S. Embarazo y artritis reumatoide .Harefuah. 2007; 146 (4):301 - 5

  19. Ostensen M, Villiger PM. La remisión de la artritis reumatoide durante el embarazo. Semin Immunopathol. 2007 Jun; 29(2):185-91.

  20. Camacho EM, Verstappen SM, Lunt M , Bunn DK, Symmons DP. Multiple adverse pregnancy outcomes before symptom onset are associated with a worse disease outcome in women with recent-onset inflammatory. Ann Rheum Dis. 2012; 71(4):528-33.

  21. Roura X, Valeria Ríos V, Diana de la Fuente D. Fármacos durante el embarazo y métodos contraceptivos en enfermedades reumáticas. Nuevas aportaciones. Reumatol Clinica. 2010; 6(1).

  22. Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus . Arthritis Care Res (Hoboken). 2012; 64(5):668-74.

  23. Hazes JM, Van de Fe G, Krommenhoek C, Dolhain RJ: Medición de la actividad de la enfermedad durante el embarazo y la funcionalidad en los pacientes con artritis reumatoide. Artritis Rheum. 2007; 57 (5):716-22.

  24. Calvo J. Tratamiento de situaciones clínicas difíciles en pacientes con artritis reumatoide: Embarazo. Reumatol Clin. 2009; 5(1).

  25. Chambers C, Koren G, Tutuncu Z N, Jonson D , Kenneth L. Jones KL. Son los nuevos agentes utilizados para tratar la artritis reumatoide de seguridad a tomar durante el embarazo? Can Fam Physician. 2007;53(3):409-12.

  26. Kuriya B, Hernández-Díaz S, Liu J, Bermas BL, Daniel G, Solomon DH .Patterns of medication use during pregnancy in rheumatoid arthritis Arthritis Care Res (Hoboken). 2011; 63(5):721-8.

  27. Bori Segura G, Hernandez Cruz B, Gobboc M, Lanas Arbeloa A, Salazar Páramo M, Terán Estrada L .Uso apropiado de los antiinflamatorios no esteroideos en reumatología: Documento de consenso de la Sociedad Espanola de Reumatología y el Colegio Mexicano de Reumatología. Reumatol Clin. 2009;5(1):3-12.

  28. Makol A, Wright K, Amin S.Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management. Drugs.2011;71(15):1973-87.

  29. Meriño-Ibarra E, Delgado Beltrán C. Rheumatoid arthritis: how to use drugs during pregnancy and lactation? Reumatol Clin. 2011;7(4):262-6.

  30. Fischer-Betz R, Specker C, Schneider M .Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra). Clin Exp Rheumatol. 2011;29(6):1021-3.

  31. Mesquita Ciconelli R .Fármacos utilizados em reumatologia no gravidez .En:Guia de Medicina Ambulatorial e Hospitalar da UNIFESP-EPM . 2ta ed. Brasilia. Manole Ltd. 2010: 499-508.




2020     |     www.medigraphic.com